ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed Jan 30, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
Common Stock
2012-01-17+464→ 94,486 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.